FLT3 and acute myeloid leukemia: Regarding the duration of FLT3 TKI efficacy after several courses of the drugs, a recent retrospective study reported the outcome of FLT3-mutated AML patients who received sequential courses of FLT3 TKI because of AML relapse [62].